|
Partnership
| 
SoCalBio
Partners With FedEx to Offer up to 35% Discounts on Shipping Services
to SoCalBio Members Through the BioBusiness Solutions Program... Learn more | |
Thanks to SoCalBio Weekly Update Sponsor
|
|
Featured SoCalBio Service Provider
Bingham
McCutchen LLP is a law firm offering a broad range of market-leading
practices focused on global financial services firms and Fortune 100
companies. The firm has 1,100 lawyers in the U.S., Europe and Asia.... learn more
| |
Join SoCalBio
|
Recommended Events
September 7 - 9 Boston, MA 
September 26- 28
Washington DC 
October 3-5
Pasadena, CA
|
Join SoCalBio
Join
SoCalBio leaders to promote the biotech and device industries in the
Greater Los Angeles Metro Area for job creation and overall economic
growth.
When you join, you will enjoy significant discounts
on products and services from lab and office supplies to insurance and
scientific publications. Discounts are exclusive to SoCalBio member
companies in Los Angeles, Orange, Ventura, Santa Barbara, Riverside and
San Bernardino counties... Click here to see why
|  |
| Thanks to SoCalBio Media Partners
|
|
|
RSVP Now
| |
SoCalBio Networking Forum in Los Angeles County
Beyond Borders: Global Biotechnology Report 2011
Ernst & Young will
present highlights from its 25th annual industry report "Beyond
Borders". Speakers during this networking forum will discuss
implications for bioscience companies as they face a more uncertain
future in the current business climate. Ernst & Young will also
summarize the sector's performance using key metrics - financial
performance, financing, deals and pipeline productivity.
Thursday, July 28, 2011 from 4:00 PM - 7:00 PM (PT)
Los Angeles, CA | Ernst & Young's Office in Downtown Los Angeles
|
|
Welcome, New SoCalBio Member
| |
(Pasadena)
Amicrobe,
Inc. uses advanced synthetic biopolymer chemistry to create materials
that can prevent and treat infections. These materials can be designed
to have broad-based antimicrobial activities as well as to support wound
healing... Learn more
|
Public Policy
| |
Patent Reform Passes the US House of Representatives
 Last
week, the US House of Representatives passed a patent-reform bill
supported by the Biotechnology Industry Organization and many affiliated
regional bioscience associations including SoCalBio. The House bill, H.R. 1249, aka the "America Invents Act", passed on Thursday with a vote of 304-117. A nearly identical bill, S. 23,
passed the Senate in March by an even more lopsided margin of 95-5. One
major reform in both the House and Senate versions of the bill is a
change from the current "invented first" system to a "filed first"
system... Read more
|
Inhaled Insulin
| |
Studies Show No Increased Risk of Cardiac Events in Diabetes Patients Treated with MannKind's AFREZZA
|  "In
response to the recent concern over the cardiovascular risk of diabetes
therapies, it is important to carefully analyze all trials and maintain
an ongoing program of safety surveillance," said Anders H. Boss, M.D.,
M.F.P.M., Senior Vice President and Chief Medical Officer at the
Valencia-based MannKind Corporation. "These most recent safety findings
add to the growing body of evidence that AFREZZA may be a promising new
therapy for patients with type 1 and type 2 diabetes, without the
concern of increased risk for cardiovascular events" ... Read more |
Cosmetic Medicine
| |
Allergan
Receives FDA Approval for First-of-Its-Kind, Fully in vitro, Cell-Based
Assay for BOTOX and BOTOX Cosmetic (onabotulinumtoxinA)
| |
The newly approved assay will be implemented immediately for release of
product for sale in the United States. Allergan estimates that use of
the new assay will reduce the use of animal-based assay testing for
BOTOX and BOTOX Cosmetic by up to 95 percent or more over the next three
years, as other regulatory agencies around the world approve this new
assay ... Read more.
|
Patenting
| |
ImmunoCellular Therapeutics' Cancer Vaccine Technology Issued Key Patent
 Patent
No. 7,939,090, entitled "System and method for the treatment of cancer,
including cancers of the central nervous system," covers the
combination of a dendritic cell based vaccine combined either before or
concurrently with chemotherapy at the recurrence of the disease.
ImmunoCellular believes that in the treatment of cancer, particularly
cancers of the central nervous system such as glioblastoma multiforme
(GBM), a dual therapeutic approach that includes the administration of a
dendritic cell-based cancer vaccine combined with a regimen of
chemotherapy could substantially enhance the clinical efficacy of
treatment... Read more
|
Funding
| |
Avita Medical Closes Equity Raising AUD$9m
| |
The
Northridge-based Avita announced it has closed the placement of its
capital raising announced on 17 May 2011. The Company raised a total of
AUD$9 million at an issue price of $0.10 per share. The placement was
managed by Wilson HTM, with shares placed with Australian and
international institutions together with sophisticated and professional
investors. The placement was led by Australian Ethical Investments and
closed oversubscribed.... Read more
Ivantis Inc. Raises $17 Million
Ivantis Inc., an Irvine, Calif.-based developer of treatments for glaucoma, has raised $17 million in new VC funding from Delphi Ventures and New Enterprise Associates ... Read more
|
Jobs Available
| |
IntriMed Technologies (Ventura)
C3 Jian (Inglewood)
Nanogea (Culver City)
Anchen Pharmaceutical (Irvine)
|
|
| About SoCalBio |
 SoCalBio
membership links you to partners, contract manufacturers, regulatory
and legal experts, and policy makers. The organization's programs help
emerging biotech and medical device companies grow. Membership is
affordable -- as low as $500 -- and offers access to networking
opportunities, advocacy, discounts through our group purchasing program group purchasing program and other benefits you simply can't find elsewhere ... Join SoCalBio |
|
|
